ILiAD Biotechnologies, LLC: ILiAD Biotechnologies Announces First School-Age Participants Enrolled in BPZE1 Pertussis Vaccine Phase 2b SUPER Clinical Trial : vimarsana.com

ILiAD Biotechnologies announces enrollment of the first participants in the SUPER Trial (Standing Up to PERtussis) the first study in school-age children of BPZE1, a live attenuated intranasal pertussis

Related Keywords

Australia , United States , United Kingdom , France , French , American , Keith Rubin , Kostenloser Wertpapierhandel , Camille Locht , Neal Halsey , Ken Solovay , Us Centers For Disease , National Institute Of Health , French National Institute Of Health , Iliad Biotechnologies , National Institute Of Allergy , Infectious Diseases , American Academy , Advisory Board , Chief Executive Officer , Institut Pasteur De Lille , French National Institute , Vanderbilt Vaccine , Treatment Evaluation Unit , National Institute , Infectious Disease , Disease Control , Private Securities Litigation Reform Act , Iliad , Iotechnologies , Nnounces , Irst , Chool , Articipants , Nrolled , Pze1 , Ertussis , Accine , Hase , Uper , Linical , Rial ,